• Emergency uses of the vaccine have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019
    (COVID-19). The Moderna
    COVID-19 Vaccine is authorized in individuals
    6 months of age and older as a primary series. The Moderna COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals

    6 months through 5 years of age at least 2 months after the Moderna COVID-19 Vaccine primary series and is authorized in individuals 6 years of age and older at least 2 months after any authorized or approved vaccine.

  • The EUA for these products is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.

  • For more information on the EUA authorized uses of the vaccine, refer to the Fact Sheets for Healthcare Providers Administering Vaccine (Vaccine Providers) and Full Prescribing Information.

Sign up to receive updates from Moderna

Storing Vaccine Vials

Multiple-dose vials are stored frozen between -50°C to -15°C (-58°F to 5°F). During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light.

Unpunctured vials can be stored refrigerated between 2°C to 8°C (36°F to 46°F) for up to 30 days prior to first use or cool storage up to room temperature between 8°C to 25°C (46°F to 77°F) for up to 24 hours prior to first use. Never refreeze once thawed.

After the first dose has been withdrawn, the vial should be held between 2°C to 25°C (36°F to 77°F). Vials should be discarded 12 hours after the first puncture. Thawed vials can be handled in room light conditions. Do not refreeze once thawed. Total storage at 8°C to 25°C (46°F to 77°F) must not exceed 24 hours.

When extracting only booster doses or a combination of primary series and booster doses, the maximum number of doses that may be extracted from either vial presentation should not exceed 20 doses. Do not puncture the vial stopper more than 20 times. If the vial stopper has been punctured 20 times, discard the vial and contents.

Learn more about
storage and handling

If for any reason you believe some vials have
experienced a temperature excursion,
use our Temperature Excursion Tool
for further instructions.

Temperature excursion tool

Vial Puncture
Moderna COVID‑19 Vaccine Video

Manufacturing and Shipment

Vaccine distributed in the US is manufactured in collaboration with our partners.

The Moderna COVID‑19 vaccines are supplied in the following multiple-dose vial presentations:

  • 5.5 mL vial with a red cap and blue border for primary series doses (12 years of age and older)
  • 2.5 mL vial with a dark blue cap and purple border for primary series doses (6-11 years of age)
  • 2.5 mL vial with a dark blue cap and magenta border for primary series doses (6 months-5 years of age)
  • 2.5 mL vial with a dark blue cap and gray border Bivalent booster doses (6 years of age and older)
  • 0.4 mL vial with a dark pink cap and yellow box on the label for Bivalent Booster doses (6 months through 5 years of age)

A carton of Moderna COVID‑19 Vaccine contains 10 multiple-dose vials. A case includes 12 cartons, or a total of 120 vials. A shipping pallet may include up to 198 cases.

The dimensions of a carton of vaccine are 5.4” x 2.1” x 2.4”.

The Moderna COVID-19 Vaccine should be transported in the frozen state. If transport at -50°C to -15°C (-58°F to 5°F) is not feasible, available data support transportation of one or more thawed vials for up to 12 hours at 2°C to 8°C (36°F to 46°F) when shipped using shipping containers which have been qualified to maintain 2°C to 8°C (36°F to 46°F) and under routine road and air transport conditions with shaking and vibration minimized. Once thawed and transported at 2°C to 8°C (36°F to 46°F), vials should not be refrozen and should be stored at 2°C to 8°C (36°F to 46°F) until use.

Counterfeit Identification

Moderna is committed to safety and ensuring that people have accurate information about the investigational Moderna COVID‑19 Vaccine, including how it is accessed and administered.

Moderna is actively monitoring for fraudulent offers of illegitimate Moderna COVID‑19 Vaccine to protect individuals from products that might be dangerous and lead to serious and life-threatening harm.

Keep in mind that under the EUA issued by FDA:

  • The Moderna COVID‑19 Vaccine is only administered as an intramuscular injection by a healthcare professional.
  • The Moderna COVID‑19 Vaccine is not taken orally and is not available as a capsule, tablet, or any other formulation.

Authentic Moderna COVID‑19 Vaccine, manufactured by Moderna, will include the Moderna name and logo on the label and is dispensed in a vial with a red or dark blue cap.

The Moderna COVID‑19 Vaccine is not sold online.

The authenticity of products acquired outside of the legitimate supply chain cannot be verified by Moderna. If you suspect the Moderna COVID‑19 Vaccine you have purchased may be counterfeit, please call Moderna Medical Information at 1-866-MODERNA (1-866-663-3762).